¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"drug"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • generic drug name
    ÀϹݾà¸í
  • idiosyncratic drug response
    ƯÀ̾๰¹ÝÀÀ
  • multiple drug resistance
    ´Ù¾àÁ¦³»¼º, ¿©·¯¾àÀúÇ×
  • transdermal drug delivery system
    °æÇǾ๰Àü´Þü°è
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • drug resistance transfer factor
    ¾àÁ¦³»¼ºÀü´ÞÀÎÀÚ
  • drug resistant bacterium
    ¾àÁ¦³»¼º¼¼±Õ
  • drug shock
    ¾à¹°Ãæ°Ý(¡­õú̪).
  • drug shop =d. store
    ¾à¹° ÀǾ౹(ËâË´).
  • drug therapy
    ¾à¹° ¾à¹°¿ä¹ý(¡­èþÛö).
  • drug tolerance
    ¾à¹°<¾àÁ¦>³»¼º.
  • drug tolerance
    ¾à¹°³»¼º(å·ÚªÒ±àõ).
  • drug treatment
    ¾à¹°¿ä¹ý(¡­èþÛö).
  • drug urticaria
    ¾à¹° µÎµå·¯±â
  • drug utilization review
    ¾à¹°»ç¿ë °ËÅä.
  • drug withdrawal
    ¾à¹°±Ý´Ü(Ð×Ó¨).
  • drug withdrawal
    ¾à¹°±Ý´Ü.
  • drug, designer
    º¯Á¶(³²¿ë)¾à¹°
  • drug-fast
    ¾à¹° ¾à¹°³»¼º(å·ÚªÒ±àõ)ÀÇ.
  • drug-induced
    ¾à¹°À¯¹ß¼º(¡­ë¯Û¡àõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • ear drug
    ±Í¾à
  • ethical drug
    Àü¹®ÀǾàǰ.
  • extended action of drug
    È®´ë¾àÈ¿.
  • fixed drug eruption
    °íÁ¤¾àÁø.
  • habit forming drug
    ½À°ü¼º¾à¹°(ã§Î±àõå·Úª).
  • hallucinogenic drug See hallucinogen
    ȯ°¢Á¦(ü³ÊÆð¥)
  • hematinic drug
    Á¶Ç÷¾à(ðãúìå·).
  • hematological drug
    Ç÷¾×ÀÛ¿ë¾à(úìäûíÂéÄå·).
  • hydrophilic drug
    Ä£¼ö¼º ¾àÁ¦.
  • ideosyncratic drug response
    ƯÀ̼º ¾à¹° ¹ÝÀÀ
  • intravenous drug abuse
    Á¤¸Æ³» ¾à¹° ³²¿ë
  • jaundice, drug-induced
    ¾à¹°À¯¹ß¼ºÈ²´Þ(å·Úªë¯Û¡àõüÜÓ¸)
  • lipid-soluble drug
    Áö¿ë¼º¾à¹°
  • liquid drug
    ¾×Á¦(äûð¥).
  • long acting drug
    Áö¼Ó¼º¾à(ò¥áÙàõå·).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ADME [drug] absorption, distribution, metabolism, and excretion
ADP adenopathy; adenosine diphosphate; administrative psychiatry; approved drug product; area diastolic ...
ADR activation, depression, repetition [in bone remodeling]; adrenodoxin reductase; Adriamycin; adverse ...
AED antiepileptic drug; antihidrotic ectodermal dysplasia; automatic external defibrillator
AHD acquired hepatocerebral degeneration; acute heart disease; antihyaluronidase; antihypertensive drug;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
DD Drug discrimination
DLST Drug lymphocyte stimulation test
DME drug metabolizing enzyme
DUE Drug usage evaluation
DIP Drug-induced Parkinsonism
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
  • JrId: 21665
    JournalTitle: Drug delivery.
    MedAbbr: Drug Deliv
    ISSN: 1071-7544
    ESSN:
    IsoAbbr:
    NlmId: 9417471
  • JrId: 25462
    JournalTitle: reviews and commentaries in antimicrobial and anticancer chemotherapy.
    MedAbbr: Drug Resist Updat
    ISSN: 1368-7646
    ESSN:
    IsoAbbr: Drug Resist. Updat.
    NlmId: 9815369
  • JrId: 27403
    JournalTitle: Drug and alcohol review.
    MedAbbr: Drug Alcohol Rev
    ISSN: 0959-5236
    ESSN:
    IsoAbbr:
    NlmId: 9015440
  • JrId: 27596
    JournalTitle: Drug research reports.
    MedAbbr: Drug Res Rep
    ISSN: 0012-6608
    ESSN:
    IsoAbbr:
    NlmId: 7701581
  • JrId: 27719
    JournalTitle: Drug merchandising.
    MedAbbr: Drug Merch
    ISSN: 0012-6586
    ESSN:
    IsoAbbr:
    NlmId: 16640250
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • J70.4
    Drug-induced interstitial lung disorder, unspecified
    »ó¼¼ºÒ¸íÀÇ ¾à¹°À¯¹ß¼º »çÀÌÁú¼º ÆóÀå¾Ö
  • G72.0
    Drug-induced myopathy
    ¾à¹°À¯¹ß¼º ±ÙÀ°º´Áõ
  • D59.2
    Drug-induced nonautoimmune haemolytic anaemia
    ¾à¹°À¯¹ß¼º ºñÀÚ°¡¸é¿ª¼º ¿ëÇ÷¼º ºóÇ÷
  • E66.1
    Drug-induced obesity
    ¾à¹° À¯¹ß¼º ºñ¸¸
  • M81.4
    Drug-induced osteoporosis
    ¾à¹° À¯¹ß¼º °ñ´Ù°øÁõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • drug-assisted interview
    ¾à¹° ÀÌ¿ë ¸é´ã
  • drug-induced
    ¾à¹° À¯¹ß¼º
  • drug-induced allergic hepatopathy
    ¾à¹° ¾Ë·¹¸£±â¼º °£º´Áõ, ¾à¹° À¯¹ß ¾Ë·¹¸£±â¼º °£º´Áõ
  • drug-induced autoantibody
    ¾à¹° À¯Àμº ÀÚ°¡ Ç×ü
  • drug-induced cholestais
    ¾àÁ¦¼º ´ãÁó ¿ïü
  • drug-induced enanthema
    ¾à¹° À¯µµ¼º Á¡¸·Áø
  • drug-induced hemolytic anemia
    ¾à¹°¼º ¿ëÇ÷¼º ºóÇ÷, ¾àÁ¦ À¯¹ß¼º ¿ëÇ÷¼º ºóÇ÷
  • drug-induced immune complex
    ¾àÁ¦ À¯¹ß¼º ¸é¿ª º¹ÇÕü
  • drug-induced leukopenia
    ¾à¹°¼º ¹éÇ÷±¸ °¨¼ÒÁõ
  • drug-induced lupus
    ¾à¹° À¯¹ß ·çǪ½º
  • drug-induced psychosis
    ¾à¹° À¯¹ß Á¤½ÅÁõ
  • drug-induced rhinitis
    ¾à¹° ºñ¿°, ¾à¹°¼º ºñ¿°
    µ¿ÀǾî=rhinitis medicamentosa.
  • drug-induced thrombocytopenic purpura
    ¾à¹°¼º Ç÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹ÝÁõ
  • fixed drug enanthema
    °íÁ¤ ¾à¹°¼º Á¡¸·Áø
  • Food and Drug Administration
    ½ÄǰÀǾà±â±¸
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 13 ÆäÀÌÁö: 5
drug-induced diarrhoea <gastroenterology> Diarrhoea may be produced by several mechanisms. Laxatives may produce diarrhoea by increasing the flow of water into the intestine or by increasing the intestinal motility.
Antibiotic medications can cause diarrhoea by killing the normal bacteria that live in the intestine and help us digest our food. Some drugs produce diarrhoea as a side effect or as drug toxicity.
(27 Sep 1997)
drug-induced disease <pharmacology> A toxic reaction to or morbid condition resulting from the administration of a drug.
(05 Mar 2000)
drug-induced eosinophilic lung disease <radiology> Diffuse reticular pattern: nitrofurantoin, Loeffler-like pattern: penicillin, sulfonamides, ASA, para-ASA, imipramine, HCTZ, cromolyn sodium see: eosinophilic lung disease
(12 Dec 1998)
drug-induced hepatitis <hepatology, pathology> Inflammation and hepatocellular damage of the liver that is caused by a drug.
Some medications may cause inflammation of the liver as a drug side effect or drug toxicity. Drugs that are known to cause hepatitis include acetaminophen, isoniazid, halothane, methyldopa, erythromycin and oral contraceptives.
(27 Sep 1997)
drug-induced lupus <dermatology> An inflammatory autoimmune disorder, similar to lupus, that develops in response to the use of a particular medication. It is characterised by anti-histone antibodies. More benign than the usual disease, with less renal involvement. The syndrome clears after stopping the offending drug.
Drugs that are known to cause this reaction include procainamide, isoniazid, sulphasalazine, hydralazine, methyldopa, phenytoin, chlorpromazine and penicillamine.
The arthritis, cardiac, pulmonary and systemic features may be present, but the kidney involvement (nephritis) and neurologic disease are rare.
Symptoms generally resolve spontaneously after stopping the medication. Complications include myocarditis, pericarditis, thrombocytopenic purpura and infections.
(18 Jul 2002)
drug-induced tremor <neurology, pharmacology> A drug-induced condition where there is shaking (tremor) of the extremities that is increased with purposeful movement.
Drugs known to induce tremor include: theophylline, Alupent, cyclosporine, amphetamines, lithium and caffeine.
(27 Sep 1997)
druggist Old common term for pharmacist.
(05 Mar 2000)
drugs toxic to lung <radiology> Bleomycin, methotrexate, cytoxan, amiodarone
(12 Dec 1998)
drugs, chinese herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesised compounds manufactured in china.
(12 Dec 1998)
drugs, essential Drugs considered essential to meet the health needs of a population as well as to control drug costs. (world health organization action programme on essential drugs, 1994, p3)
(12 Dec 1998)
drugs, generic Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.
(12 Dec 1998)
drugs, investigational Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (treatment ind). The main heading includes drugs under investigation in foreign countries.
(12 Dec 1998)
drugs, non-prescription Drugs that can be sold legally without a prescription.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 5
  • Drug Interactions - »õâ The action of a drug that may affect the activity, metabolism, or toxicity of another drug.
    Synonyms : Drug Interaction, Interaction, Drug, Interactions, Drug
  • Drug Labeling - »õâ Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.
    Synonyms : Drug Labelling, Drug Package Insert, Drug Package Inserts, Drug Product Labeling, Insert, Drug Package, Inserts, Drug Package, Labeling, Drug Product, Labelling, Drug, Package Insert, Drug
  • Drug Monitoring - »õâ The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.
    Synonyms : Drug Monitoring, Therapeutic, Monitoring, Therapeutic Drug
  • Drug Packaging - »õâ Containers, packaging, and packaging materials for drugs and biological products. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available.
    Synonyms : Drug Containers, Container, Drug, Containers, Drug, Drug Container, Drug Packagings, Packagings, Drug
  • Drug Residues - »õâ Drugs and their metabolites which are found in the edible tissues and milk of animals after their medication with specific drugs. This term can also apply to drugs found in adipose tissue of humans after drug treatment.
    Synonyms : Drug Residue, Residue, Drug, Residues, Drug
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
drug tolerance A condition that occurs when the body gets used to a medicine so that either more medicine is needed or different medicine is needed.
Ãâó: www.seniormag.com/conditions/cancer/cancerglossary...
drug resistance The result of changes in microbes that reduce or eliminate the effectiveness of medicines that are designed to cure or prevent infections.
Ãâó: www.ecohealth101.org/glossary.html
drug resistance refers to the ability of cancer cells to become resistant to the effects of the chemotherapy drugs used to treat cancer. dysplasia - abnormal development of tissue. dyspnea - difficulty or painful breathing.
Ãâó: www.chw.org/display/PPF/DocID/2010/router.asp
drug abuse The use of a drug for a purpose other than that for which it is normally prescribed or recommended.
Ãâó: www.finr.com/glossary.html
drug resistance the failure of (cancer) cells to respond to drugs (chemotherapy).
Ãâó: www.lymphomainfo.net/lymphoma/glossary.html
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 5
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á